Fetal Monitors in Colorado

Ultrasound AI is a healthcare technology company founded in 2019 that develops AI-powered software tools for maternal and neonatal healthcare. The company's flagship product, Delivery Date AI™, uses artificial intelligence trained on over 8 million ultrasound images to accurately predict delivery dates in singleton pregnancies (14–36 weeks gestation) where a reliable estimated delivery date is unavailable. Delivery Date AI™ received FDA De Novo authorization in 2026 and is currently approved for clinical use in the United States, Brazil, and Chile. The company also developed Preterm AI™, designed to identify risks of preterm birth and enable proactive clinical interventions. Ultrasound AI holds six issued patents across three countries and positions its solutions as decision-support tools that augment clinician judgment in obstetric care, addressing the critical clinical need for accurate pregnancy dating to improve maternal and neonatal outcomes.

C.R. Bard (now part of BD) is a diversified global medical technology company operating through multiple business segments: BD Interventional, BD Life Sciences, and BD Medical. The company manufactures and distributes an extensive portfolio of medical devices, consumables, and diagnostic solutions across vascular access, medication delivery, infection prevention, laboratory diagnostics, surgical instruments, and specialty medical equipment. Through the Medivance acquisition (2011), Bard offers the Arctic Sun™ Targeted Temperature Management system for precise patient temperature control in critical care settings. The company serves hospitals, healthcare systems, clinical laboratories, and other healthcare facilities with products spanning syringes and needles, catheters (central and peripheral), infusion systems, surgical mesh and grafts, diagnostic culture media, molecular testing systems, blood collection products, stents, and specialty equipment for urology, cardiology, gynecology, and interventional medicine. With thousands of SKUs across therapeutic areas including vascular surgery, gastrointestinal care, wound management, and microbiology solutions, Bard functions as a comprehensive B2B medical device and consumables supplier.

PharmaJet is a needle-free injection technology company founded in 2005 and headquartered in Golden, Colorado. The company develops innovative jet injection systems designed to improve vaccine and pharmaceutical delivery while addressing critical healthcare challenges including needle reuse, needlestick injuries, and infection transmission. PharmaJet's proprietary needle-free systems deliver injectable drugs with precision and safety across therapeutic areas including vaccines, immunotherapy, and oncology treatments. The company has established partnerships with over 80 global pharmaceutical manufacturers, government health agencies including the World Health Organization, and public health organizations. PharmaJet's technology has demonstrated clinical benefits: 97% vaccinator preference, 25% faster administration workflow, 54% reduction in adverse events, and improved immunization coverage. The systems are designed to be cost-effective, reusable, require no drug reformulation, and integrate seamlessly with existing fill-finish manufacturing processes. PharmaJet serves healthcare providers, pharmaceutical partners, and patients globally with regulatory-cleared delivery systems.

Newman Medical designs and manufactures Doppler ultrasound systems and vascular testing devices for non-invasive physiological assessment of peripheral arterial disease, venous insufficiency, and fetal monitoring. Founded in 2005 and based in the Denver, Colorado area, the company specializes in three primary product lines: DigiDop arterial Dopplers for vascular assessment, simpleABI ankle-brachial index (ABI) systems for PAD diagnosis, and DigiDop Fetal Dopplers for prenatal care. All products are American-designed and manufactured in-house, with interchangeable probes for versatility across examination sites. DigiDop systems feature high-sensitivity blood flow detection technology and are backed by industry-leading 5-year warranties covering parts, labor, and accidental breakage. The simpleABI systems are PC-based, user-friendly platforms offering cost-effective, reimbursable PAD diagnosis with 2-year comprehensive warranty. Newman Medical serves healthcare providers through direct sales and an established network of national and international distributors. The company emphasizes responsive technical support from vascular specialists and quality control throughout the manufacturing process. Products are used in clinical settings requiring rapid, accurate vascular diagnosis and prenatal monitoring without invasive procedures.